Sedia Biosciences

About:

Sedia Biosciences develops and sells medical diagnostic tests and monitoring tools used to battle against pandemics.

Website: http://www.sediabio.com/

Twitter/X: Sediabio

Top Investors: National Institutes of Health

Description:

It is Sedia's mission to provide more cost effective and accessible diagnostic testing by advancing the widespread use of innovative surveillance and monitoring tools, and point-of-care diagnostic testing. Our objectives are to become a leader in advancing access to medical care by (1) focusing on point-of-care diagnostics and (2) developing innovative diagnostic, surveillance and monitoring tools that enable more cost effective deployment of resources by healthcare providers. With headquarters in Portland, Oregon, USA, Sedia brings together a dedicated team of researchers and scientists that share our common mission - to improve access to medical care around the world by providing innovative diagnostic products.

Total Funding Amount:

$3.28M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Portland, Oregon, United States

Founded Date:

2009-01-01

Contact Email:

customerservice(AT)sediabio.com

Founders:

Roger Gale, Ronald Mink

Number of Employees:

11-50

Last Funding Date:

2016-08-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai